Get Quotes

Market Menu

INCOME STATEMENTS-Aarey Drugs & Pharmaceuticals Ltd.

You can view the income statements for the last 5 years.

BSE

Jul 19
50.45 -1.17 ( -2.27%)
Volume 6005
Prev. Close 51.62
Open Price 50.59
Today's Low / High
50.00
     
51.18
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
30.00
     
68.00

NSE

Jul 19
50.44 -1.41 ( -2.72%)
Volume 23993
Prev. Close 51.85
Open Price 53.00
Today's Low / High
50.00
     
53.00
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
29.95
     
68.00
ISIN No INE198H01019 Market Cap. ( Rs. in Cr. ) 141.51 P/BV 1.07 Book Value ( Rs. ) 47.33
BSE Code 524412 52 Week High/Low ( Rs. ) 68/30 FV/ML 10/1 P/E(X) 30.22
NSE Code AAREYDRUGSEQ Book Closure 05/09/2023 EPS ( Rs. ) 1.67 Div Yield (%) 0.00
( Rs. in Crs. )
ParticularsMar 24Mar 23Mar 22Mar 21Mar 20
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]395.62418.96492.68348.42300.09
Total Operating Revenues395.62418.96492.68348.42300.09
      
Other Income6.962.732.757.016.69
Total Revenue402.58421.69495.43355.43306.78
      
EXPENSES     
Cost Of Materials Consumed387.760.000.000.000.00
Purchase Of Stock-In Trade0.00418.98467.29339.25285.93
Changes In Inventories Of FG,WIP And Stock-In Trade-5.86-15.144.78-1.464.25
Employee Benefit Expenses0.720.810.980.400.40
Finance Costs4.382.872.002.431.79
Depreciation And Amortisation Expenses1.701.571.990.920.89
Other Expenses8.556.588.375.596.28
Total Expenses397.24415.68485.40347.13299.54
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax5.346.0110.038.307.24
      
Profit/Loss Before Tax5.346.0110.038.307.24
      
Tax Expenses-Continued Operations     
Current Tax0.661.782.611.661.50
Deferred Tax0.00-0.04-0.110.12-0.05
Tax For Earlier Years0.000.500.980.000.00
Total Tax Expenses0.662.243.481.791.45
Profit/Loss After Tax And Before ExtraOrdinary Items4.683.776.546.515.79
      
Profit/Loss From Continuing Operations4.683.776.546.515.79
      
Profit/Loss For The Period4.683.776.546.515.79
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)1.841.492.722.792.48
Diluted EPS (Rs.)1.841.492.722.792.80
ParticularsMar 24
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]395.62
Total Operating Revenues395.62
Other Income6.96
Total Revenue402.58
EXPENSES 
Cost Of Materials Consumed387.76
Purchase Of Stock-In Trade0.00
Changes In Inventories Of FG,WIP And Stock-In Trade-5.86
Employee Benefit Expenses0.72
Finance Costs4.38
Depreciation And Amortisation Expenses1.70
Other Expenses8.55
Total Expenses397.24
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax5.34
Profit/Loss Before Tax5.34
Tax Expenses-Continued Operations 
Current Tax0.66
Deferred Tax0.00
Tax For Earlier Years0.00
Total Tax Expenses0.66
Profit/Loss After Tax And Before ExtraOrdinary Items4.68
Profit/Loss From Continuing Operations4.68
Profit/Loss For The Period4.68
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)1.84
Diluted EPS (Rs.)1.84